Looking at options history for SpringWorks Therapeutics (NASDAQ:SWTX) we detected 68 trades. If we consider the specifics of each trade, it is accurate to state that 42% of the investors opened ...

Wall Street expects a year-over-year increase in earnings on higher revenues when SpringWorks Therapeutics (SWTX) reports results for the quarter ended December 2024. While this widely-known ...

For SWTX (NASDAQ:SWTX), we notice a call option trade that happens to be bearish, expiring in 7 day(s) on February 21, 2025. This event was a transfer of 50 contract(s) at a $50.00 strike.

$SWTX insiders have traded $SWTX stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales. We have seen ...

Daniel Pichl, the Chief People Officer of $SWTX, sold 13,750 shares of the company on 02-10-2025 for an estimated $728,997. We received data on the trade from a ...

SpringWorks Therapeutics Inc (NASDAQ:SWTX) is set to release its Q4 2024 earnings on February 20, 2025. The consensus estimate for Q4 2024 revenue is $59.12 million, and the earnings are expected to ...

In trading on Tuesday, shares of SpringWorks Therapeutics Inc (Symbol: SWTX) crossed above their 200 day moving average of $37.59, changing hands as high as $38.43 per share. SpringWorks ...

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...

(RTTNews) - SpringWorks Therapeutics Inc. (SWTX) announced that the U.S. Food ... of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan ...

In this article, we are going to take a look at where SpringWorks Therapeutics Inc. (NASDAQ:SWTX) stands against the other ...

Stock analysts at HC Wainwright dropped their FY2024 earnings per share estimates for SpringWorks Therapeutics in a research note issued on Wednesday, February 12th. HC Wainwright analyst R. Burns now ...